Graphite Bio, Inc.
NASDAQ:GRPH
3.18 (USD) • At close March 21, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|---|
Revenue
| 0 | 0 | 0 | 0 | 0 |
Cost of Revenue
| 2.407 | 8.346 | 0.734 | 0.121 | 0 |
Gross Profit
| -2.407 | -8.346 | -0.734 | -0.121 | 0 |
Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 |
Reseach & Development Expenses
| 29.73 | 72.787 | 37.932 | 9.123 | 0 |
General & Administrative Expenses
| 40.973 | 32.852 | 22.511 | 4.377 | 0.029 |
Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 |
SG&A
| 40.973 | 32.852 | 22.511 | 4.377 | 0.029 |
Other Expenses
| 62.081 | 0 | -10.317 | -54.833 | 0 |
Operating Expenses
| 70.703 | 105.639 | 60.443 | 13.5 | 0.029 |
Operating Income
| -73.11 | -105.639 | -60.443 | -13.5 | -0.029 |
Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 |
Total Other Income Expenses Net
| -51.541 | 4.587 | -10.317 | -54.873 | -0.08 |
Income Before Tax
| -124.651 | -101.052 | -70.76 | -68.373 | -0.109 |
Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 |
Income Tax Expense
| 0 | -4.587 | -11.051 | -54.793 | 0.08 |
Net Income
| -124.651 | -96.465 | -59.709 | -13.58 | -0.189 |
Net Income Ratio
| 0 | 0 | 0 | 0 | 0 |
EPS
| -15.3 | -12.31 | -14.45 | -2.78 | -0.09 |
EPS Diluted
| -15.3 | -12.31 | -14.45 | -2.78 | -0.09 |
EBITDA
| -70.703 | -105.639 | -70.76 | -68.212 | -0.029 |
EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 |